Junru Feng

发表

DIS3L2 promotes progression of hepatocellular carcinoma via hnRNP U-mediated alternative splicing.

Zhaoyong Li, P. Gao, Huafeng Zhang, 2019, Cancer research.

Non‐canonical phosphoglycerate dehydrogenase activity promotes liver cancer growth via mitochondrial translation and respiratory metabolism

L. Ye, Huafeng Zhang, Yingli Zhou, 2022, The EMBO journal.

Glycine cleavage system determines the fate of pluripotent stem cells via the regulation of senescence and epigenetic modifications

P. Gao, Huafeng Zhang, Yang Cao, 2019, Life Science Alliance.

Metformin sensitises hepatocarcinoma cells to methotrexate by targeting dihydrofolate reductase

Huafeng Zhang, Xiuying Zhong, Linchong Sun, 2021, Cell Death & Disease.

Pyrimidine Metabolism-related gene RRM2 as a novel biomarker for Prognosis and immunotherapy in LUAD

J. Li, Qing Ye, Beibei Huang, 2022 .

Everolimus shows synergistic antimyeloma effects with bortezomib via the AKT/mTOR pathway

Hui Liu, R. Fu, Zhaoyun Liu, 2018, Journal of Investigative Medicine.

Secreted protease PRSS35 suppresses hepatocellular carcinoma by disabling CXCL2-mediated neutrophil extracellular traps

Huafeng Zhang, Xiuying Zhong, Yongping Cai, 2023, Nature Communications.

Genome-wide CRISPR screen identifies synthetic lethality between DOCK1 inhibition and metformin in liver cancer

K. Qu, Pengfei Cai, Huafeng Zhang, 2022, Protein & Cell.